Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample collection, processing and storage

M T Landi1, N Caporaso

  • 1Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7360, USA.

IARC Scientific Publications
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Systematic review with meta-analysis: impact of one-handed vs. two-handed technique on quality outcomes of colonoscopy.

European review for medical and pharmacological sciences·2019
Same author

POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

The British journal of dermatology·2018
Same author

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.

Blood cancer journal·2017

Collecting biospecimens for biomarker studies in epidemiology requires careful attention to processing, storage, and quality control. Proper handling ensures the validity of results derived from these valuable biological samples.

Area of Science:

  • Epidemiology
  • Molecular Biology
  • Biomarker Research

Background:

  • Advancements in molecular biology enable biomarker use in epidemiology.
  • Biospecimen banking for cohort studies presents unique challenges.
  • Clinical sample handling provides a basis but requires epidemiological adaptation.

Purpose of the Study:

  • To review critical issues in biospecimen inclusion for epidemiological studies.
  • To highlight methodological considerations for valid biomarker utilization.
  • To emphasize the importance of quality control in biospecimen handling.

Main Methods:

  • Review of current practices and challenges in biospecimen collection and processing.
  • Examination of various biospecimen types used in epidemiological research.

Related Experiment Videos

  • Discussion of factors impacting sample integrity and biomarker stability.
  • Main Results:

    • Technical advances increase feasibility but also complexity and cost.
    • Diverse biospecimen types (blood, urine, tissue, air, etc.) are utilized.
    • Potential distortions from processing, storage, shipping, and timing are identified.

    Conclusions:

    • Meticulous attention to biospecimen processing and handling is crucial for validity.
    • Quality control protocols are essential for reliable epidemiological biomarker studies.
    • Careful management of biospecimens maximizes the potential of biomarker discovery.